Case report shows clinical benefits for Argent BioPharma's CannEpil in a paediatric patient with Lennox-Gastaut Syndrome. #ASX #health $RGT Argent BioPharma stockhead.com.au/health/positiv…

👏 Grateful to see this article in Australian highlighting a positive case study supporting cannabinoid-based treatment for drug-resistant epilepsy. 𝗣𝗿𝗼𝘂𝗱 𝘁𝗼 𝗯𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀. 🔗 bit.ly/3Rt8UAC #Epilepsy #Pharma #MedicalInnovation

🧠 Promising Results In Treatment-Resistant Epilepsy This Pharma Now article highlights a promising case study in the Epilepsy field. It’s rewarding to see our work included in the discourse. 🔗pharmanow.live/latest-news/ca… #Epilepsy #NeuroImmune #Biotech #Research

🧠 𝗡𝗼𝘁 𝗮𝗹𝗹 𝗲𝗽𝗶𝗹𝗲𝗽𝘀𝘆 𝗿𝗲𝘀𝗽𝗼𝗻𝗱𝘀 𝘁𝗼 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁. This Johns Hopkins Medicine article explains refractory epilepsy—a form that doesn’t improve with standard meds. 🔗 Learn more: hopkinsmedicine.org/health/conditi… #Epilepsy #RefractoryEpilepsy #HealthEquity

🌍 This article states that epilepsy affects 50M people worldwide, with up to 30% living with drug-resistant epilepsy. Since current options can’t provide seizure freedom for these patients, developing new treatments is essential. 🔗 bit.ly/3QOOu9v

.Argent BioPharma has signed a binding term sheet to acquire the key assets and intellectual property of formerly ASX-listed AusCann Group in a deal worth around US$15 million. #ASX $RGT buff.ly/4hCY73H

Argent BioPharma (ASX:RGT) has signed a binding term sheet to acquire the key assets and intellectual property of AusCann Group Holdings Ltd. (which was delisted from the ASX in August 2024) in a US$15 million all-share transaction | announcements.asx.com.au/asxpdf/2025081… Argent BioPharma $RGT

✨ Highlights from Small Caps today ✨ This article covers our acquisition of key assets from AusCann Group and highlights the strengthening of our clinical pipeline and expansion into Europe 🌍. 📰 Read more: smallcaps.com.au/argent-biophar… #PharmaNews #Biotech #RGT

🚀 Stocks Down Under reports that our 𝘀𝗵𝗮𝗿𝗲𝘀 𝗷𝘂𝗺𝗽𝗲𝗱 𝟴𝟲% following the AusCann acquisition, reflecting strong investor confidence. 📰 Read more: stocksdownunder.com/argent-shares-… #Biotech #Investors #MarketNews #RGT

Independent in vivo study demonstrates up to 85% survival in a viral inflammatory mouse model treated with Argent BioPharma's ArtemiC. #ASX #health $RGT stockhead.com.au/health/us-in-v…

📰 This article reports that a US in vivo study showed ArtemiC™ achieved 85% survival in a viral inflammatory model — highlighting its potential. Read more: stockhead.com.au/health/us-in-v… #PreclinicalResearch #ARDS #DrugDevelopment #Biotech #RGT

#Argent is Growing Through M&A: Projected #Merged #Company #Value of $100M in AC8 #Asset #Acquisition tinyurl.com/mmzx7uen Argent BioPharma

🌍 Featured in Yahoo Finance ! This article reports on our acquisition of AusCann’s core assets as a step toward our planned U.S. national exchange listing. 💪 📰 Read more: finance.yahoo.com/news/argent-gr… #Biotech #PharmaNews #RGT

💡According to this article, many people with focal epilepsy experience seizures for at least a year after starting treatment as physicians work to find the right drug and dosage. Read more: shorturl.at/sAFK6 #EpilepsyAwareness #Neurology #MedicalResearch #RGT

🔬Our 𝗥&𝗗 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝘆 revolves around understanding the immune system intricacies and embracing the multidiscilinary approach - developing multi-target therapies for 𝗰𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝗺𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁. #Pharma #MedicalResearch #Biotech #RGT

🧠 This article reports on the multiple factors that drive Alzheimer's—amyloid-β, metal imbalance, enzyme dysregulation, neuroinflammation... That’s why multi-target therapies may hold more promise than single-target ones. 🔗 pubs.rsc.org/en/content/art… #Alzheimers #Innovation #RGT

🧠 What is the CNS? According to the Cleveland Clinic, the central nervous system consist of the brain & spinal cord, which control movements, process senses & keep the body running. Read more: my.clevelandclinic.org/health/body/ce… #CNS #NeuroImmune #MedicalResearch #RGT

We are driven by our mission to integrate science, technology, and expertise to proactively combat diseases collaboratively. Learn more on our website: argentbiopharma.com #RGT #Innovation #MedicalResearch

📌 This article highlights how complex 𝗖𝗡𝗦 𝗱𝗿𝘂𝗴 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 can be and how nanotherapeutics may pave new paths forward. 📰 Read more: pubs.rsc.org/en/Content/Art… #Nanotechnology #CNS #NeuroImmune #Innovation #Biotech